International Centre For Diarrhoeal Disease Research, Bangladesh

This early-stage trial tested whether ivermectin, a well-known anti-parasitic drug, could safely treat post-kala-azar dermal leishmaniasis (PKDL), a skin condition that can spread the parasite causing kala-azar. Thirty adults in Bangladesh received either ivermectin or the standa…

This small study tested the safety and effectiveness of the drug ivermectin for people with a skin condition called PKDL, which can appear after recovery from visceral leishmaniasis. Ten otherwise healthy adults with PKDL skin rashes took ivermectin pills for three months. The go…

This study followed 599 mothers and children in Bangladesh who took part in an earlier program that provided parenting support and cash transfers when the children were infants. Now that the children are 6-9 years old, researchers measured their IQ, reading, math skills, and home…